Cargando…

Fumarate drives EMT in renal cancer

Detalles Bibliográficos
Autores principales:	Sciacovelli, Marco, Frezza, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	News and Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260501/ https://www.ncbi.nlm.nih.gov/pubmed/27886164 http://dx.doi.org/10.1038/cdd.2016.137

Ejemplares similares

Post-translational regulation of metabolism in fumarate hydratase deficient cancer cells
por: Gonçalves, Emanuel, et al.
Publicado: (2018)

Exploiting tumour addiction with a serine and glycine-free diet
por: Amelio, Ivano, et al.
Publicado: (2017)

A new dimension in drug discovery: reversing epithelial–mesenchymal transition (EMT)
por: Yun-Ju Huang, Ruby, et al.
Publicado: (2016)

Oncometabolites: Unconventional triggers of oncogenic signalling cascades
por: Sciacovelli, Marco, et al.
Publicado: (2016)

Fumarates in dermatology
por: Rajagopalan, Murlidhar
Publicado: (2011)

Fumarate hydratase (FH) and cancer: a paradigm of oncometabolism
por: Valcarcel-Jimenez, Lorea, et al.
Publicado: (2023)

Fumarate Hydratase Loss Causes Combined Respiratory Chain Defects
por: Tyrakis, Petros A., et al.
Publicado: (2017)

RUNX1, a new regulator of EMT in breast cancer
por: Khawaled, Saleh, et al.
Publicado: (2017)

Fumarate induces redox-dependent senescence by modifying glutathione metabolism
por: Zheng, Liang, et al.
Publicado: (2015)

Stem cells: a window of opportunity in low-dimensional EMT space
por: Nie, Qing
Publicado: (2018)

Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition
por: Sciacovelli, Marco, et al.
Publicado: (2016)

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus–1 Infection: Week 48 Results of the DRIVE-AHEAD Trial
por: Orkin, Chloe, et al.
Publicado: (2019)

Fumarate induces vesicular release of mtDNA to drive innate immunity
por: Zecchini, Vincent, et al.
Publicado: (2023)

Discovery of a novel target for renal cell carcinoma: transglutaminase 2
por: Kang, J H, et al.
Publicado: (2016)

Succinate Anaplerosis Has an Onco-Driving Potential in Prostate Cancer Cells
por: Sant’Anna-Silva, Ana Carolina B., et al.
Publicado: (2021)

HIF and fumarate hydratase in renal cancer
por: Sudarshan, S, et al.
Publicado: (2007)

New view in cell death mode: effect of crystal size in renal epithelial cells
por: Sun, X-Y, et al.
Publicado: (2015)

Cyclin A2, Rho GTPases and EMT
por: Bendris, Nawal, et al.
Publicado: (2012)

Difference drives division
por: Wells, William A.
Publicado: (2005)

Agrin drives synaptogenesis
por: Tuma, Rabiya S.
Publicado: (2005)

On the connections between cancer stem cells and EMT
por: Cioce, Mario, et al.
Publicado: (2012)

Key roles of EMT for adaptive resistance to MEK inhibitor in KRAS mutant lung cancer
por: Kitai, Hidenori, et al.
Publicado: (2016)

Interleukins drive the cell cycle
por: Tuma, Rabiya S.
Publicado: (2005)

Protrusion drives osteoclast fusion
por: Short, Ben
Publicado: (2012)

Myosin drives bladder movements
por: Short, Ben
Publicado: (2009)

Ubiquitin drives cilia shortening
por: Choi, Eun
Publicado: (2009)

Reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells
por: Zheng, Liang, et al.
Publicado: (2013)

Catastrophe gradient drives anaphase B
por: LeBrasseur, Nicole
Publicado: (2007)

Rab35 drives exosome secretion
por: Short, Ben
Publicado: (2010)

Gluconeogenesis combats cancer: opening new doors in cancer biology
por: Khan, M W, et al.
Publicado: (2015)

Chronic Obstructive Pulmonary Disease (COPD) and Lung Cancer: Epithelial Mesenchymal Transition (EMT), the Missing Link?
por: Sohal, Sukhwinder Singh
Publicado: (2015)

Fumarate hydratase loss promotes mitotic entry in the presence of DNA damage after ionising radiation
por: Johnson, Timothy I., et al.
Publicado: (2018)

Dynactin drives dynein without microtubule binding
por: Williams, Ruth
Publicado: (2007)

CCR4 drives ATLL jail break
por: Shannon, Kevin M.
Publicado: (2014)

Zambia’s drive to eliminate malaria faces challenges
Publicado: (2018)

Prospects of adjuvant RANKL inhibition in breast cancer?
por: Rachner, T D, et al.
Publicado: (2015)

New light on Smac mimetics and breast cancer
por: Cornmark, L, et al.
Publicado: (2016)

Were mitochondrial contractions driving the cellular energy cycle?
por: Powell, Kendall
Publicado: (2005)

SRGP-1 drives cell junctions round the bend
por: Short, Ben
Publicado: (2010)

Fueling the fire: Src family kinases drive inflammation
por: Ley, Klaus
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_op6j31va6o11h7pr1m9jp7mfn8